Status:
TERMINATED
Content Validation of Quality of Life and Symptom Questionnaires for Pheochromocytoma and Paraganglioma
Lead Sponsor:
Molecular Insight Pharmaceuticals, Inc.
Conditions:
Pheochromocytoma
Paraganglioma
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this qualitative study is to evaluate the clarity and comprehensiveness of two disease-specific questionnaires, and to evaluate how effective these questionnaires are at assessing the q...
Eligibility Criteria
Inclusion
- Provide written informed consent and be willing to comply with protocol requirements
- Participant is aged ≥ 18
- Have a documented (medical record) diagnosis of either pheochromocytoma or paraganglioma with active symptoms or within 60 days of curative therapy
Exclusion
- Patient is currently asymptomatic from pheochromocytoma/paraganglioma diagnosis or duration \> 60 days from curative therapy
- Participant has a clinically significant disorder, including alcohol or drug abuse, which may interfere with study participation or which may affect the outcome of the study as judged by the investigator.
- Participant has a mental disability or significant mental illness, legal incapacity or limited legal capacity or any other lack of fitness, in the investigator's opinion, to preclude the subject's participation in or ability to complete the study.
- Participant is currently too unwell to take part in the study.
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00911729
Start Date
April 1 2009
Last Update
June 10 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oxford Outcomes- Nationwide Recruitment within the US
Bethesda, Maryland, United States, 20814